DHR Potential Buy setupReasons for bullish bias:
- Price bounced from support
- Entry is at breakout of HH
- DOW theory, SL at last HL
Entry Level (CMP): 244.95
Stop Loss Level: 222.23
Take Profit Level 1: 267.67
Take Profit Level 2: 290.39
5.85EUR
4.32 BEUR
21.64 BEUR
675.16 M
About DANAHER CORP
Sector
Industry
CEO
Rainer M. Blair
Website
Headquarters
Washington
Employees (FY)
63 K
Founded
1984
ISIN
US2358511028
FIGI
BBG000J2YX68
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
DHR - ATH again soonLeaders lead. Has delivered incredible value to shareholders over the last decade. No reason to doubt why it couldn't continue.
Break out of this the daily range should push it to 270 soon.
Disclaimer: no position yet.
Danaher Corp. | Buy Scenario | Wine and waterDanaher in an interesting spot. We are under a resistance level (Resistance area 1) however the level was engulfed already (see orange marking). Looking to buy into if the following should develop:
1. Price breaks above Buy area 1 i want to see a close and open of a weekly or daily candle atleast.
DHR Sell off Misunderstood.The recent DHR Sell off is Misunderstood IMO.
Thoughts where that the recent weight loss drugs innovation will negate the need for life or medical device support for these patient types.
And while this is true in the short term, it does not negate the requirements - unless a complete reversal of the
DHR, Massive BULLISH Wedge-Formation, Major BREAKOUT Incoming!Hello There!
Welcome to my new analysis of DHR. The stock market is in a really important condition currently as there are many interesting stock gems within the market I have spotted in my analytics backend. One of the interesting gems I recently spotted for a major opportunity on the long side o
Danaher (DHR): Life Sciences GiantA Great Business | Fund Favorite | Danaher is a stock Mutual and Hedge Funds Love | The company has a stellar high-moat M&A-driven business model with strong pricing power and often anti-cyclical customers | Compounder Starts To Look Attractive
Dividend Stock Brilliance | Danaher has a wide-moat bu
watching DHR for a potential short-term bullish trade"Based on 17 Wall Street analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is $277.76 with a high forecast of $310.00 and a low forecast of $250.00. The average price target represents a 19.37% change from the last price of $232.69."
- Tipranks
DHR with a bearish outlook following its earnings #StocksThe PEAD projected a bearish outlook for DHR after a negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 40%.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where DAP is featured.
Frequently Asked Questions
The current price of DAP is 226.20 EUR — it has increased by 0.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange DANAHER CORP stocks are traded under the ticker DAP.
DANAHER CORP is going to release the next earnings report on Apr 23, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DANAHER CORP has a max estimate of 282.00 EUR and a min estimate of 202.10 EUR.
DAP earnings for the last quarter are 1.91 EUR whereas the estimation was 1.71 EUR which accounts for 11.75% surprise. Estimated earnings for the next quarter are 1.73 EUR. See more details about DANAHER CORP earnings.
DANAHER CORP revenue for the last quarter amounts to 6.50 B EUR despite the estimated figure of 6.24 B EUR. In the next quarter revenue is expected to reach 5.55 B EUR.
Yes, you can track DANAHER CORP financials in yearly and quarterly reports right on TradingView.
Like other stocks, DAP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DANAHER CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 63.00 K employees. See our rating of the largest employees — is DANAHER CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DANAHER CORP EBITDA is 7.47 B EUR, and current EBITDA margin is 31.16%. See more stats in DANAHER CORP financial statements.